Author:
Purohit Samit,Bhise Rohan,Appachu Sandhya,Lakshmaiah K. C.,Govindbabu K.
Publisher
Springer Science and Business Media LLC
Reference22 articles.
1. Benjamin R, Pisters Peter WT, Helman LJ, Bramwell Vivien HC, Rubin BP, O’Sullivan B (2008) Sarcomas of soft tissue. In: Abeloff MD, Armitage JO, Niederhuber JE, Kastan MB, McKeena WG (eds) Clinical oncology, 4th edn. Churchill Livingstone Elsevier, Philadelphia, pp 2009–2056
2. Santoro A, Tursz T, Mouridsen H, Verweij J, Steward W, Somers R et al (1995) Doxorubicin versus CyVADIC versus doxorubicin plus ifosfamide in first-line treatment of advanced soft tissue sarcomas: a randomized study of the European Organization for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group. J Clin Oncol 13:1537–1545
3. Lorigan P, Verweij J, Papai Z, Rodenhuis S, Le Cesne A, Leahy MG et al (2007) Phase III trial of two investigational schedules of ifosfamide compared with standard-dose doxorubicin in advanced or metastatic soft tissue sarcoma: A European Organisation for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group study. J Clin Oncol 25:3144–3150
4. Verma S, Younus J, Stys-Norman D, Haynes AE, Blackstein M, Members of the Sarcoma Disease Site Group of Cancer Care Ontario’s Program in Evidence-Based Care (2008) Meta-analysis of ifosfamide-based combination chemotherapy in advanced soft tissue sarcoma. Cancer Treat Rev 34:339–347
5. Sauer R, Schuchardt U, Hohenberger W, Wittekind C, Papadopoulos T, Grabenbauer GG et al (1999) Neoadjuvant radiochemotherapy in soft tissue sarcomas. Optimization of local functional tumor control. Strahlenther Onkol 175:259–266
Cited by
9 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献